LALPATHLAB price chart
Daily close · 5-year history
Instrument details
Identifiers & classification
- Symbol
- LALPATHLAB
- MB Code
- MBEQU1729
- ISIN
- INE600L01024
- BSE code
- 539524
- Industry group
- Healthcare Services
- Screener
- View peers →
Latest earnings
Most recent declared quarter
- Quarter
- Mar 2026
- Revenue
- 702.7 Cr
- Net profit
- 132.2 Cr
- EPS
- 7.85
- YoY revenue
- +16.61%
Company documents
12 PDFs across 4 categories
Audited annual reports & financial statements
Earnings call transcripts & Q&A
Investor decks & strategy updates
Exchange filings & corporate announcements
Corporate timeline
Earnings, news & corporate actions for LALPATHLAB
Dividend of ₹4.00 per share
Ex-date corporate action
Dr Lal PathLabs reported Q2 FY26 profit up 16% YoY to ₹152 crore and announced a ₹7 interim dividend along with a 1:1 bonus issue, signal…
Dr Lal PathLabs hit a 20% upper circuit after Q4FY26 results showed 16.6% YoY revenue growth; brokerages remained bullish on the diagnost…
Dr. Lal PathLabs jumped 17.87% after Q4 results showed consolidated net profit of Rs 132 crore in Q4 FY26, down 15.1% year-on-year, despi…
EPS 7.85 vs est. 7.70
Beat estimates by 2.00%
Dr Lal PathLabs posted audited standalone and consolidated results for Q4 and FY ended March 31, 2026, and the board approved a final div…
Dividend of ₹3.50 per share
Ex-date corporate action
EPS 7.21 vs est. 6.94
Beat estimates by 3.84%
Price returns
Historical performance
Technicals
Indicator consensus